Viewing Study NCT02847234


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-03-01 @ 8:53 PM
Study NCT ID: NCT02847234
Status: UNKNOWN
Last Update Posted: 2016-07-28
First Post: 2016-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Factors Associated With Complications of Cervical Necrotizing Fasciitis
Sponsor: Hospices Civils de Lyon
Organization:

Study Overview

Official Title: Factors Associated With Complications of Cervical Necrotizing Fasciitis
Status: UNKNOWN
Status Verified Date: 2016-07
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Cervical necrotizing fasciitis (CNF) is a rare but severe complication of pharyngeal or dental infections. The infection can rapidly descend into the mediastinum and lead to a life-threatening prognosis. Treatment consists of a multidisciplinary approach in intensive care with radiologist and with early and repeated surgical debridement. Anti-inflammatory drugs have been incriminated by authors in the development of necrotizing fasciitis. Recently, a single-center study demonstrated that pharyngeal source of CNF and oral glucocorticoid intake before admission was associated with the occurrence of mediastinitis.

The aim of the study is to assess the incidence and factors associated with CNF complications, in particular mediastinitis. Secondary outcome is to describe patient characteristics, medical and surgical management.

Methods: A retrospective, observational, non-interventional multicentre study is conducted in nine intensive care units in France from January 2005 to December 2016.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: